知镜 Cognispect · 医学文献与研究工作台

Treatment of children and young adults with a Fontan circulation and cardiovascular dysfunction. 2026 Consensus Statement from the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AHA, AEPC, EACTS, ISACHD, ISHLT and PICS.

Opotowsky AR, Allen KY, Chessa M, Crossland D, Grewal J, Hörer J, Karamlou T, Liuba P, Lorts A, Marsden A, Miyamoto SD, Smith CL, Bruaene AV, Voges I, Hansmann G.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2026-11-03 · PMID 43018530

文献摘要

The Fontan operation enables long term survival for many individuals born with single ventricle heart disease, but the resulting circulation imposes a lifelong hemodynamic burden and predisposes to cardiovascular dysfunction and multisystem morbidity. Evidence based guidance for assessment and management of Fontan specific cardiac and vascular dysfunction, however, remains limited. The European Pediatric Pulmonary Vascular Disease Network (EPPVDN) convened an international, multidisciplinary executive writing group to review the available literature and develop consensus recommendations addressing cardiovascular dysfunction in children and young adults with a Fontan circulation. Recommendations were graded using established Class of Recommendation and Level of Evidence criteria adapted to the Fontan specific evidence base. The statement addresses cardiovascular assessment, pulmonary vascular disease and use of pulmonary vasodilator therapy, Fontan pathway obstruction, systemic venous and arterial abnormalities and collateral vessels, lymphatic dysfunction and intervention, myocardial dysfunction and heart failure therapy, and thromboembolic risk and antithrombotic therapy. The focus is on phenotype-guided management, hemodynamically informed treatment decisions, and medical, transcatheter, and surgical approaches tailored to Fontan circulation. Seven graded recommendation tables as well as a flowchart for considerations regarding pulmonary vasodilator therapy are provided to support clinical decision making. Fontan-specific evidence remains limited, so many recommendations necessarily represent expert opinion. This EPPVDN consensus statement, therefore, discusses knowledge gaps and priorities for collaborative research to improve outcomes for individuals living with a Fontan circulation.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。